Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing

Carlo Curti; Daniel J. Kirby; Craig A. Russell

doi:10.1007/s40964-020-00127-5

Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing

Carlo Curti, Daniel J. Kirby, Craig A. Russell

Research output: Contribution to journal › Review article › peer-review

Abstract

Three-dimensional (3D) printing technologies are continuously applied to novel fields, laying the foundations for a new industrial revolution. With regard to pharmaceutical sciences, 3D printed drug products are emerging as attractive and innovative tools in personalised medicine. For example, solid oral dosage forms (e.g. tablets) can be printed in a wide range of dosages, release profiles, geometries and sizes by simply modifying a digital model, thus providing patients with tailored therapies. Various 3D printing technologies have been applied to pharmaceutical manufacture in recent years, and different materials have been investigated to fabricate solid oral dosage forms in a broad range of properties. Therefore, the aim of this review is to describe the state of the art of 3D printing oral pharmaceuticals, with the view to provide formulation scientists with essential information to approach the development of 3D printed drug products, from digital design to final product quality control. Short- to long-term potential areas of application of 3D printed drug products and their relative regulatory pathway challenges are also presented.

Original language	English
Pages (from-to)	111-123
Number of pages	13
Journal	Progress in Additive Manufacturing
Volume	5
Issue number	2
Early online date	21 Mar 2020
DOIs	https://doi.org/10.1007/s40964-020-00127-5
Publication status	Published - 1 Jun 2020

Bibliographical note

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Keywords

Drug delivery
Personalised medicine
Solid oral dosage forms
Three-dimensional printing

Access to Document

10.1007/s40964-020-00127-5Licence: CC BY 3.0

Current formulation approaches in design and development
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 2.02 MBLicence: CC BY 3.0

Cite this

@article{0d331803cc4e48faa022fcd584da491c,

title = "Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing",

abstract = "Three-dimensional (3D) printing technologies are continuously applied to novel fields, laying the foundations for a new industrial revolution. With regard to pharmaceutical sciences, 3D printed drug products are emerging as attractive and innovative tools in personalised medicine. For example, solid oral dosage forms (e.g. tablets) can be printed in a wide range of dosages, release profiles, geometries and sizes by simply modifying a digital model, thus providing patients with tailored therapies. Various 3D printing technologies have been applied to pharmaceutical manufacture in recent years, and different materials have been investigated to fabricate solid oral dosage forms in a broad range of properties. Therefore, the aim of this review is to describe the state of the art of 3D printing oral pharmaceuticals, with the view to provide formulation scientists with essential information to approach the development of 3D printed drug products, from digital design to final product quality control. Short- to long-term potential areas of application of 3D printed drug products and their relative regulatory pathway challenges are also presented.",

keywords = "Drug delivery, Personalised medicine, Solid oral dosage forms, Three-dimensional printing",

author = "Carlo Curti and Kirby, {Daniel J.} and Russell, {Craig A.}",

note = "This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.",

year = "2020",

month = jun,

day = "1",

doi = "10.1007/s40964-020-00127-5",

language = "English",

volume = "5",

pages = "111--123",

journal = "Progress in Additive Manufacturing",

issn = "2363-9520",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing

AU - Curti, Carlo

AU - Kirby, Daniel J.

AU - Russell, Craig A.

N1 - This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Three-dimensional (3D) printing technologies are continuously applied to novel fields, laying the foundations for a new industrial revolution. With regard to pharmaceutical sciences, 3D printed drug products are emerging as attractive and innovative tools in personalised medicine. For example, solid oral dosage forms (e.g. tablets) can be printed in a wide range of dosages, release profiles, geometries and sizes by simply modifying a digital model, thus providing patients with tailored therapies. Various 3D printing technologies have been applied to pharmaceutical manufacture in recent years, and different materials have been investigated to fabricate solid oral dosage forms in a broad range of properties. Therefore, the aim of this review is to describe the state of the art of 3D printing oral pharmaceuticals, with the view to provide formulation scientists with essential information to approach the development of 3D printed drug products, from digital design to final product quality control. Short- to long-term potential areas of application of 3D printed drug products and their relative regulatory pathway challenges are also presented.

AB - Three-dimensional (3D) printing technologies are continuously applied to novel fields, laying the foundations for a new industrial revolution. With regard to pharmaceutical sciences, 3D printed drug products are emerging as attractive and innovative tools in personalised medicine. For example, solid oral dosage forms (e.g. tablets) can be printed in a wide range of dosages, release profiles, geometries and sizes by simply modifying a digital model, thus providing patients with tailored therapies. Various 3D printing technologies have been applied to pharmaceutical manufacture in recent years, and different materials have been investigated to fabricate solid oral dosage forms in a broad range of properties. Therefore, the aim of this review is to describe the state of the art of 3D printing oral pharmaceuticals, with the view to provide formulation scientists with essential information to approach the development of 3D printed drug products, from digital design to final product quality control. Short- to long-term potential areas of application of 3D printed drug products and their relative regulatory pathway challenges are also presented.

KW - Drug delivery

KW - Personalised medicine

KW - Solid oral dosage forms

KW - Three-dimensional printing

UR - https://link.springer.com/article/10.1007/s40964-020-00127-5

UR - http://www.scopus.com/inward/record.url?scp=85082873017&partnerID=8YFLogxK

U2 - 10.1007/s40964-020-00127-5

DO - 10.1007/s40964-020-00127-5

M3 - Review article

SN - 2363-9520

VL - 5

SP - 111

EP - 123

JO - Progress in Additive Manufacturing

JF - Progress in Additive Manufacturing

IS - 2

ER -

Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Development and Characterisation of Stereolithographic 3D Printed Solid Oral Dosage Forms

Cite this

Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Student theses

Development and Characterisation of Stereolithographic 3D Printed Solid Oral Dosage Forms

Cite this